Pharmacy Practice and Science Department Highlights: May 2020

(May 1, 2020) 


Availability of information for dosing commonly used medications in special ICU populations. Am J Health-Syst Pharm 2020;77:529-34.

Hyperoncotic albumin reduces net fluid loss associated with hemodialysis. Hosp Pharm 2020;55:130-4.

Cefdinir-induced red stool and purple discoloration of nutritional formula: A case report. Journal of Infection and Chemotherapy. 26;2: 286-288.

  • Eljaaly, K
  • Alshehri, S.

Photosensitivity induced by lomefloxacin versus other fluoroquinolones: A meta-analysis. Journal of Infection and Chemotherapy. Epub ahead of print.

  • Eljaaly, K.
  • Alkhalaf, A.
  • Alhifany, A.
  • Alshibani, M.

Impact evaluation of a four-year academic-community partnership in provision of medication management and tertiary prevention services for rural patients with diabetes and/or hypertension. Preventive Medicine Reports. 2020;17; Article 101038.

Is it Time for a Quality Rating System for Colleges of Pharmacy? American Journal of Pharmaceutical Education. 2020: 84 (3); Article 7700. 

Identifying drug therapy problems through patient consultation at community pharmacies A Quality Improvement Project. Journal of Patient Safety. Published ahead of print. J Patient Saf. 2020;16(1): 19-23.

Role of clinical pharmacists and pharmacy support personnel in transitions of care. J Am Coll Clin Pharm. 2020;3:532–545.

  • Stranges, P. 
  • Jackevicius, C.
  • Anderson, S.
  • Bondi, D.
  • Danelich, I.
  • Englin, F. 
  • Hansen, M.
  • Nys, C.
  • Patel, R.
  • Hanna Phan, PharmD, FCCP, FPPA 
  • Philibrick, A.
  • Ranger, M.
  • Schumacher, C.
  • Smithgall, S.

Evidence demonstrating the pharmacist’s direct impact on clinical outcomes in pediatric patients: An Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2020. Epub ahead of print:

  • LaRochelle, J.
  • Smith, K.
  • Benavides, S.
  • Bobo, K
  • Chung, A.
  • Farrington, E.
  • Kennedy, A.
  • Knoppert, D.
  • Lee, B.
  • Manasco, K.
  • Pettit, R.
  • Hanna Phan, PharmD, FCCP, FPPA 
  • Potts, A.
  • Sandritter, T.
  • Hagemann, T.

Response to Yang, Shi, Wang, et al. Journal of the National Cancer Institute 2020;112: 428.


R21AI152394 (PI: Lussier)

NIH/National Institute of Allergy and Infectious Disease

Systems-level Genetic Patterns Underlying Disseminated Coccidioidomycosis in Humans

To discover the specific genetic factors associated with DCM pathogenesis, we will conduct genome-wide analyses on the human genetic variants and complex patterns that underlie susceptibility to disseminated coccidioidomycosis. 

Role: Scientific Advisor for Jason H. Karnes, PharmD, PhD, BCPS, FAHA